克洛法拉宾单疗法在耐火性多系统LCH中,胃肠道受影响
Stephanie Aronson1, Vivian Tang2, Klaudia Cios1
1Department of Pediatrics, Maimonides Children's Hospital, Brooklyn, New York, USA.
Pediatric hematology and oncology
|September 24, 2025
概括
胃肠道朗格汉斯细胞囊细胞瘤 (LCH) 可能对标准治疗有抗性. 克洛法拉宾作为耐火性GI-LCH病例的有效二线疗法具有前景,这表明需要修订风险分层.
科学领域:
- 儿科瘤学 儿科瘤学
- 囊细胞性疾病 囊细胞性疾病
- 胃肠道病理 胃肠道病理
背景情况:
- 朗格汉斯细胞囊炎 (LCH) 是一种罕见的多系统性囊炎性疾病.
- 在LCH中胃肠道 (GI) 干涉带来了独特的挑战,并且可能对传统疗法具有耐药性.
- 对GI-LCH的早期识别和有效的治疗策略对于患者的治疗结果至关重要.
研究的目的:
- 要突出治疗耐火性胃肠道朗格汉斯细胞囊细胞瘤 (GI-LCH) 的挑战.
- 评估克洛法拉宾在耐火性GI-LCH患者中的疗效.
- 建议重新评估GI参与LCH风险分层.
主要方法:
- 两名耐火性GI-LCH患者的病例报告.
- 对治疗方案的审查,包括芬布拉斯,普雷尼松,细胞拉宾和克洛法拉宾.
- 对治疗反应和临床缓解的分析.
主要成果:
- 两个GI-LCH病例对标准的第一线和二线治疗 (维布拉斯,普雷迪尼松,细胞氨基酸) 耐药.
- 这两位患者在使用克洛法拉宾时都实现了临床缓解.
- 这些发现表明克洛法拉宾在耐火性GI-LCH中的潜在疗效.
结论:
- 在LCH中胃肠道的参与可能需要更高风险的分类.
- 克洛法拉宾显示出作为耐火性GI-LCH的二线治疗的巨大潜力.
- 建议对克洛法拉宾作为GI-LCH的首选二线药物进行进一步的研究.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


